These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31309716)

  • 1. Serum level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a biomarker of synovitis in rheumatoid arthritis.
    Gorlier C; Gottenberg JE; Laurans L; Simon T; Ait-Oufella H; Sellam J
    Int J Rheum Dis; 2019 Sep; 22(9):1616-1618. PubMed ID: 31309716
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as biomarker to predict therapeutic response to methotrexate in rheumatoid arthritis.
    Gamez-Nava JI; Bonilla-Lara D; Ponce-Guarneros JM; Zuñiga-Mora JA; Perez-Guerrero EE; Murillo-Vazquez JD; Becerra-Alvarado IN; Rodriguez-Jimenez NA; Saldaña-Cruz AM; Vazquez-Villegas ML; Vera-Navarrete EY; Gonzalez-Ponce F; Gonzalez-Lopez L
    Innate Immun; 2017 Oct; 23(7):606-614. PubMed ID: 28876141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis.
    Molad Y; Ofer-Shiber S; Pokroy-Shapira E; Oren S; Shay-Aharoni H; Babai I
    Eur J Clin Invest; 2015 Jun; 45(6):557-64. PubMed ID: 25832796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
    Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-soluble folate receptor β as a biomarker for the activity of rheumatoid arthritis synovitis and the response to anti-TNF agents.
    Otsubo H; Tsuneyoshi Y; Nakamura T; Matsuda T; Komiya S; Matsuyama T
    Clin Rheumatol; 2018 Nov; 37(11):2939-2945. PubMed ID: 30022370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.
    Nordal HH; Brokstad KA; Solheim M; Halse AK; Kvien TK; Hammer HB
    Arthritis Res Ther; 2017 Jan; 19(1):3. PubMed ID: 28081709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Triggering Receptor Expressed on Myeloid Cells-1: Diagnosis or Prognosis?
    Lemarié J; Gibot S
    Crit Care Clin; 2020 Jan; 36(1):41-54. PubMed ID: 31733681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
    Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
    Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis.
    Rosengren S; Wei N; Kalunian KC; Kavanaugh A; Boyle DL
    Rheumatology (Oxford); 2011 Mar; 50(3):603-10. PubMed ID: 21098574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer.
    Kuemmel A; Alflen A; Schmidt LH; Sebastian M; Wiewrodt R; Schulze AB; Buhl R; Radsak M
    Sci Rep; 2018 Jul; 8(1):10766. PubMed ID: 30018308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis.
    Chang W; Peng F; Meng SS; Xu JY; Yang Y
    BMC Immunol; 2020 Jan; 21(1):2. PubMed ID: 31931717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
    Wang Y; Zhang S; Li L; Xie J
    Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cartilage oligomeric matrix protein as biomarker predicting abatacept response in rheumatoid arthritis patients with insufficient response to a first anti-TNFα treatment.
    Nguyen MVC; Adrait A; Baillet A; Trocmé C; Gottenberg JE; Gaudin P
    Joint Bone Spine; 2019 May; 86(3):401-403. PubMed ID: 30243783
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Ann Rheum Dis; 2003 May; 62(5):472-5. PubMed ID: 12695163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of ultrasound subclinical synovitis and increment of serum vascular endothelial growth factor in a patient with rheumatoid arthritis achieved in sustained clinical remission by treatment with adalimumab and methotrexate.
    Kawashiri SY; Arima K; Suzuki T; Nakashima Y; Horai Y; Okada A; Tamai M; Nakamura H; Kawakami A
    Mod Rheumatol; 2014 Jul; 24(4):681-4. PubMed ID: 24533548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.
    Kawashiri SY; Fujikawa K; Nishino A; Takatani A; Shimizu T; Umeda M; Fukui S; Igawa T; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Mizokami A; Maeda T; Kawakami A
    Int J Rheum Dis; 2019 May; 22(5):842-851. PubMed ID: 30883001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced, extremity-dedicated MRI identifies synovitis changes in the follow-up of rheumatoid arthritis patients treated with rituximab.
    Cimmino MA; Parodi M; Zampogna G; Boesen M; Kubassova O; Barbieri F; Paparo F; Garlaschi G; Cutolo M
    Clin Exp Rheumatol; 2014; 32(5):647-52. PubMed ID: 25068921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) and its soluble in the plasma form (sTREM-1) as a diagnostic biomarker in neonatal sepsis.
    Patoulias D; Kalogirou MS; Patoulias I
    Folia Med Cracov; 2018; 58(2):15-19. PubMed ID: 30467431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: three centers experience.
    Salgado E; Campos J; Moreira-Navarrete V; Mulero J; Navarro F; Pérez-Pampín E; Carmona L; Gómez-Reino J
    Joint Bone Spine; 2013 Jul; 80(4):438-40. PubMed ID: 23453477
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive factors of tumour necrosis inhibitor treatment persistence for rheumatoid arthritis: An observational study in 8052 patients.
    Fautrel B; Belhassen M; Hudry C; Woronoff-Lemsi MC; Levy-Bachelot L; Van Ganse E; Tubach F
    Joint Bone Spine; 2020 May; 87(3):267-269. PubMed ID: 31606495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.